Skip to main content
. 2015 Feb 23;10(2):e0116394. doi: 10.1371/journal.pone.0116394

Table 2. IRR for CRC in relation to the studied polymorphisms.

ncases (%) nsub-cohort (%) IRR a (95% CI) IRR b (95% CI) P-value c
TLR4 rs4986790
AA 839 (92) 1577 (92) 1.00 (ref.) 1.00 (ref.) -
GA 76 (8) 141 (8) 0.99 (0.79–1.25) 1.00 (0.79–1.26) 0.98
GG 0 (0) 1 (0) - - -
GA+GG 76 (8) 142 (8) 0.99 (0.79–1.25) 1.00 (0.79–1.26) 0.97
rs5030728
GG 405 (44) 826 (48) 1.00 (ref.) 1.00 (ref.) -
GA 399 (44) 731 (43) 1.10 (0.96–1.26) 1.11 (0.96–1.27) 0.16
AA 111 (12) 162 (9) 1.30 (1.06–1.61) 1.30 (1.05–1.60) 0.02
GA+AA 510 (56) 398 (23) 1.14 (1.00–1.30) 1.14 (1.00–1.30) 0.05
AA vs. GG+GA 111 (12) 162 (9) 1.24 (1.02–1.52) 1.24 (1.01–1.51) 0.04
NFKB1 rs28362491
Ins/Ins 320 (35) 679 (60) 1.00 (ref.) 1.00 (ref.) -
Ins/Del 449 (49) 787 (46) 1.19 (1.03–1.37) 1.19 (1.03–1.37) 0.02
Del/Del 146 (16) 253 (15) 1.13 (0.93–1.37) 1.14 (0.94–1.38) 0.18
Ins/Del+Del/Del 595 (65) 1040 (61) 1.17 (1.02–1.34) 1.17 (1.03–1.34) 0.02

a Crude—adjusted for age and sex.

b In addition, adjusted for smoking status, alcohol intake, HRT status (women only), BMI, use of NSAID, intake of red and processed meat, and dietary fibre.

c P-value for the adjusted estimates.